LGD-3303 is offered in 17mg per ml concentration. Each bottle contains at least 30ml of total volume resulting in 500mg of LGD-3303 per bottle.
LGD 3303 is a research compound being investigated for its potential of binding onto the androgenic receptors in muscles and bones. Different from anabolic compounds that bind onto all the receptors in the body, including reproductive organs, LGD 3303 may possibly bind to muscle or bone receptors only.
Studies have tested the effect of daily oral doses of LGD-3303 on strength and bone density of ovariectomized, osteopenic rats, a prevalent model used to evaluate post-menopausal osteoporosis.
The studies found LGD-3303 to be a powerful and highly selective androgen receptor full agonist in skeletal muscle, a target tissue well-known for androgen action. By comparison, in the sebaceous glands and prostate, the compound is a much weaker partial agonist. The ability of effective, pharmacological LGD-3303 to spare these non-target tissues provides a novel and potentially safer treatment for osteoporosis.
|CAS Number||917891-35-1, 1196133-39-7|
|Molar Mass||342.75 g·mol−1|
Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis and research from Trusted Sources before making any purchase based on your own personal circumstances. You should independently research and verify any information that you find on our Website and wish to rely upon.
By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority, if you are not 100% satisfied with the product you received, please contact us at firstname.lastname@example.org